Skip to main content

HEALTH

  • Pfizer exploring OTC divestiture? RB, Sanofi most likely suitors

    NEW YORK - Pfizer CEO and chairman Ian Read may have hinted earlier this month at the company's interest in divesting its consumer health unit, which recent reports value at $14 billion.

  • Topical analgesic 4Jointz hits market to relieve joint pain

     SAN FRANCISCO - Beginning this fall, all those suffering from osteoarthritis, sports injuries, and everyday wear and tear will be able to find relief as 4Jointz, a natural over-the-counter cream, launches in the United States.

    4Jointz is a clinically proven topical pain reliever that uses a novel, patented technology combining natural allantoin present in a standardized comfrey extract with tannic acid and eucalyptus oil as part of an herbal formula.

  • Bell Pharmaceuticals introduces Jet-Avert motion sickness tab

    BELL PLAINE, Minn.— Bell Pharmaceuticals on Wednesday added a new extension to its Jet line of products - Jet-Avert is a fast acting, easy-to-take motion sickness aid.  

    The super-small mini tab helps provide all day protection from nausea, dizziness and vomiting, the company stated. Targeting the chronic user, Jet-Avert is available in 24 & 100 count sizes.  

  • E-hydrate expands distribution through Walgreens and several c-store outlets

    LOS ANGELES - With a growing footprint at traditional grocery retailers, E-hydrate, the maker of natural Protein On-the-Go, recently secured distribution through Walgreens, which added E-hydrate's two flagship SKUs in the top locations across the country.

    "Customers are now actively on the lookout for healthier choices when they're on-the-go," stated Jiam Kayser, E-hydrate chief sales officer. "Walgreens is right in line with our philosophy, and we're excited about the new focus on healthy food choices at Walgreens."

  • OTC DXM drives good bargain - saving healthcare $31 billion over 10 years

    WASHINGTON - The OTC availability of dextromethorphan will save consumers and the healthcare system between $22 billion and $31 billion over the next 10 years, according to a study released Tuesday that was conducted by Charles River Associates and quantifies the savings consumers and the healthcare system receive from the over-the-counter availability of the widely used cough suppressant.

  • CRN's Supplement OWL goes live, now accepting product labels

    WASHINGTON — The Supplement OWL (Online Wellness Library) is now accepting product labels from dietary supplement finished product manufacturers and marketers as the product registry moves into its phase two of beta-testing.

  • H-E-B exclusive brand TexaClear acquires VanaPain liquid pain relievers

    ARLINGTON, Texas - The H-E-B exclusive brand TexaClear on Wednesday expanded into two SKUs of liquid pain relief with the acquired formulas formerly known as VanaPain.

    The new branding is complemented by a new and improved taste while still providing the same fast acting, liquid relief for both daytime and nighttime pains, GM Pharmaceuticals announced.

X
This ad will auto-close in 10 seconds